Echo Therapeutics Net Income

Echo Therapeutics (ECTE) currently reports a net income of $-6M as of September 2016. That compares with $-24M in the prior-year period — up 74.7% year over year. That is below the sector sector average of $100M. Use the charts on this page to explore Echo Therapeutics's net income history and peer comparisons.

Echo Therapeutics's net income increased from $-24M to $-6M — a 74.7% year-over-year increase (period ending September 2016). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Echo Therapeutics's net income of $-6M is lower than the its sector sector average of $100M. That is roughly 105.8% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Echo Therapeutics reported $-6M in net income as of September 2016. That compares with $-24M in the prior-year period — up 74.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net income of $-6M, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is $100M. From there, open related valuation or income-statement pages for Echo Therapeutics, and consider following ECTE for alerts when major investors trade the stock.